A detailed history of Ubs Asset Management Americas Inc transactions in Baxter International Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,721,246 shares of BAX stock, worth $90.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,721,246
Previous 2,742,294 0.77%
Holding current value
$90.4 Million
Previous $91.7 Million 12.64%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $691,426 - $847,392
-21,048 Reduced 0.77%
2,721,246 $103 Million
Q2 2024

Aug 13, 2024

BUY
$32.87 - $43.55 $16 Million - $21.2 Million
487,796 Added 21.64%
2,742,294 $91.7 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $131,254 - $151,663
-3,465 Reduced 0.15%
2,254,498 $96.4 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $1.34 Million - $1.65 Million
-42,281 Reduced 1.84%
2,257,963 $87.3 Million
Q3 2023

Nov 13, 2023

SELL
$37.32 - $49.29 $2.32 Million - $3.07 Million
-62,286 Reduced 2.64%
2,300,244 $86.8 Million
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $7.02 Million - $9.82 Million
-186,860 Reduced 7.33%
2,362,530 $95.8 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $13.1 Million - $15.2 Million
262,673 Added 11.49%
2,549,390 $130 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $5.55 Million - $6.89 Million
103,076 Added 4.72%
2,286,717 $123 Million
Q2 2022

Aug 12, 2022

SELL
$63.83 - $80.0 $50.6 Million - $63.4 Million
-792,937 Reduced 26.64%
2,183,641 $140 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $23.5 Million - $27.3 Million
305,529 Added 11.44%
2,976,578 $231 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $8.91 Million - $10.4 Million
119,509 Added 4.68%
2,671,049 $229 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $1.68 Million - $1.91 Million
22,839 Added 0.9%
2,551,540 $205 Million
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $6.7 Million - $7.32 Million
83,184 Added 3.4%
2,528,701 $204 Million
Q1 2021

May 14, 2021

BUY
$76.38 - $86.03 $543,596 - $612,275
7,117 Added 0.29%
2,445,517 $206 Million
Q4 2020

Mar 01, 2021

BUY
$75.39 - $82.36 $6.2 Million - $6.77 Million
82,213 Added 3.49%
2,438,400 $196 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $2.38 Million - $2.75 Million
30,347 Added 1.3%
2,356,187 $189 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $11.4 Million - $13.6 Million
-144,463 Reduced 5.85%
2,325,840 $200 Million
Q1 2020

May 15, 2020

BUY
$71.57 - $93.3 $23.1 Million - $30.1 Million
322,815 Added 15.03%
2,470,303 $201 Million
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $5.82 Million - $6.71 Million
-75,832 Reduced 3.41%
2,147,488 $180 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $7.36 Million - $8.11 Million
90,372 Added 4.24%
2,223,320 $194 Million
Q2 2019

Aug 15, 2019

BUY
$73.44 - $82.41 $6.51 Million - $7.31 Million
88,664 Added 4.34%
2,132,948 $0
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $5.15 Million - $6.49 Million
79,844 Added 4.06%
2,044,284 $0
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $8.97 Million - $11.4 Million
146,031 Added 8.03%
1,964,440 $129 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $11.7 Million - $12.8 Million
-165,161 Reduced 8.33%
1,818,409 $0
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $13.6 Million - $16.2 Million
-214,527 Reduced 9.76%
1,983,570 $0
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $3.39 Million - $3.91 Million
54,109 Added 2.52%
2,198,097 $0
Q4 2017

Feb 09, 2018

SELL
$61.45 - $66.05 $8.11 Million - $8.71 Million
-131,905 Reduced 5.8%
2,143,988 $0
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $135 Million - $147 Million
2,275,893
2,275,893 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.